BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Countries EMEA (Middle East & Africa)

Eisai Expands Direct Presence in Saudi Arabia with New Pharmaceutical Sales Subsidiary

Eisai announced the commencement of full-scale operations at Eisai Pharmaceuticals Single Person Limited Liability Company (Eisai Saudi Arabia), a wholly-o...

October 02, 2024 | News

Minovia Therapeutics Receives FDA Clearance to Initiate Phase Ib Trial for Mitochondrial Cell Therapy in Low-Risk MDS Patients

MNV-201 is a mitochondrial cell therapy product composed of autologous hematopoietic stem cells enriched with allogeneic mitochondria In pre-clini...

September 27, 2024 | News

UAE Approves LEQEMBI® for Early Alzheimer’s Treatment, Marking a Milestone in Regional Healthcare

Eisai Co., Ltd. and Biogen Inc. announced today that the Ministry of Health and Prevention in the United Arab Emirates (UAE) has approved humanized anti-so...

August 14, 2024 | News

SoniVie Presents Promising REDUCED-1 Study Results for TIVUS™ System at EuroPCR Conference

SoniVie, which has developed a novel proprietary Therapeutic Intra-Vascular Ultrasound System (TIVUS™) to treat a variety of hypertensive disorders, ...

July 25, 2024 | News

Lunit's AI-Powered Breast Cancer Detection Solution Adopted by Qatar’s National Screening Program

Lunit, a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the implementation of its AI-powered breast canc...

July 23, 2024 | News

Sabin Vaccine Institute Launches Phase 2 Trial for Sudan Ebolavirus Vaccine in Uganda

Sabin Vaccine Institute launched a Phase 2 clinical trial for its vaccine against Sudan ebolavirus, with healthy volunteers receiving the single-...

July 16, 2024 | News

Merck and Afrigen Partner in South Africa to Develop mRNA Platform Technology, Boosting Global Vaccine Access

Aim of the collaboration is to develop mRNA platform technology, scale up and troubleshoot challenges in mRNA process optimization Contributes to expand...

July 05, 2024 | News

APPIS Innovator Program 2024 Winners Announced

The APPIS Innovator Program 2024 has concluded with an impressive showcase of 49 entries from 21 countries, each addressing critical barrie...

July 04, 2024 | News

Genoks and Velsera Partner to Transform Cancer Diagnostics and Treatment in Turkey

Genoks, a leading Turkish genomics healthcare company, and Velsera, a global healthcare technology company offering a universal software platform to connec...

July 01, 2024 | News

PharmaJet’s Needle-Free Tropis® System to Drive House-to-House Polio Immunization Campaign in Somalia

PharmaJet®, a company dedicated to enhancing the performance and outcomes of injectables through innovative delivery systems, today announced that thei...

June 28, 2024 | News

Juniper Biologics Expands Distribution Rights for Caris Life Sciences' Advanced Cancer Profiling Services to Middle East and Africa

Singapore-headquartered Juniper Biologics Pte Ltd (Juniper), a leading healthcare and pharmaceuticals company focused on commercialising novel therapies, h...

June 24, 2024 | News